Regulatory Bodies including FDA EPA and ECB to Present at the Lhasa Limited Symposium on New Horizons in Toxicity Prediction



All speakers will be presenting on current approaches to toxicity prediction , including Dr Edwin Matthews of the US FDA who will be giving an overview of toxicity prediction methodologies from a pharmaceutical regulatory perspective. Also relevant to the area of medicine, Dr Romauldo Benigni of the Italian National Institite of Health will present strengths and limitations of models and databases for the prediction of genetic and carcinogenic toxicity.

Focusing on the areas of industrial chemical toxicity and environmental risk assessment, Dr Akihiko Hirose of the NIHS will be speaking on emerging areas and technologies covering toxicity biomarkers in predictive systems. In addition Dr Ann Richard will be explaining how the US EPA is currently broadening the foundations for improved toxico-chemoinformatics through the application of computational chemistry in the area of environmental toxicology. Dr Andrew Worth of the ECB will also present on in-silico toxicity prediction tools & Guidance developed by the European Chemicals Bureau.

The Lhasa Symposium will also feature presentations from several industry and academic speakers, and to conclude the event a panel discussion session will explore future needs and challenges in toxicity prediction . Expert panelists will invite audience participation and offer views and opinions from regulatory, commercial and academic perspectives.

The Lhasa Symposium will take place on December 8th and 9th at the University of Cambridge, UK. For further information and to register please visit http://www.lhasasymposium.com .





Regulatory Bodies including FDA EPA and ECB to Present at the Lhasa Limited Symposium on New Horizons in Toxicity Prediction